Pharmacokinetics and Biopharmaceutics of Biologics

APV-Course no. 6379, 20 and 21 June 2011, Berlin

(PresseBox) ( Mainz, )
This course is designed to cover basic aspects of the non-clinical PK-development of biologics. Biologics have some special features influencing their metabolic pathways, distribution behaviour and PK/PD relationship. In contrast to small molecules biologics are usually inherently immunogenic with possible consequences on their PK/PD-behaviour and safety profile, requesting as well a broader bioanalytical methodology.

This course will present and explain several of these features by established scientists and developers in this field employing state of the art case studies on a basic, yet sufficiently detailed level to allow acquisition of the knowledge necessary to translate the principles into the daily work. Emphasis will be given to a conceptual understanding of the theory and practical use of pharmacokinetic and biopharmaceutic criteria for biologics within the overall non-clinical strategy and regulatory environment. The course will encourage the design of pharmacokinetic development programmes and enable the choice to be made of development compounds with appropriate pharmacokinetic properties. After attending this course, participants will be able to apply these principles in an up-to-date and practical way in an industrial, academic or regulatory setting. Attendees will also be better equipped to communicate successfully in meet ings involving project scientists, regulators and pharmacokineticists.

In addition to lectures, time allows for both formal and informal discussions and for networking with peers.

For more detailed information on the current programme please use the following link:
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to